# reload+after+2024-01-21 05:45:47.335884
address1§103 Carnegie Center Drive
address2§Suite 309
city§Princeton
state§NJ
zip§08540
country§United States
phone§609 486 2308
website§https://www.lianbio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn's disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03 for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.
fullTimeEmployees§163
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Konstantin  Poukalov', 'age': 39, 'title': 'Founder & Executive Chairman', 'yearBorn': 1984, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Adam Leo Stone', 'age': 43, 'title': 'Interim CEO & Director', 'yearBorn': 1980, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Yi  Larson M.B.A.', 'age': 43, 'title': 'Treasurer', 'yearBorn': 1980, 'fiscalYear': 2022, 'totalPay': 1408499, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ehong  Gu', 'title': 'Interim CFO, VP & Head of Global Finance', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Brianne  Jahn', 'age': 37, 'title': 'Chief Business Officer', 'yearBorn': 1986, 'fiscalYear': 2022, 'totalPay': 697467, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jiang  Qian', 'age': 54, 'title': 'Chief Commercial Officer & GM of China', 'yearBorn': 1969, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Michael  Humphries M.D.', 'title': 'Chief Scientific Advisor', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.154
currency§USD
dateShortInterest§1702598400
forwardEps§0.02
pegRatio§0.14
exchange§NGM
quoteType§EQUITY
shortName§LianBio
longName§LianBio
firstTradeDateEpochUtc§1635773400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§f81cec73-1f77-34c7-bba7-e7e32beb34f1
gmtOffSetMilliseconds§-18000000
targetHighPrice§4.0
targetLowPrice§2.94
targetMeanPrice§3.31
targetMedianPrice§3.0
recommendationMean§3.3
recommendationKey§hold
numberOfAnalystOpinions§3
quickRatio§9.913
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
